Alana T Brennan, Emma M Kileel, Siyabonga Khoza, Nigel J Crowther, Jacob Bor, Matthew P Fox, Sydney Rosen, Patricia Hibberd, Frederick Raal, Kamy Chetty, Koleka Mlisana, Jaya A George
{"title":"在南非公共医疗机构进行肌酐检测的成年人中慢性肾病的患病率和进展:一项利用南非国家卫生实验室服务(NHLS)数据的研究。","authors":"Alana T Brennan, Emma M Kileel, Siyabonga Khoza, Nigel J Crowther, Jacob Bor, Matthew P Fox, Sydney Rosen, Patricia Hibberd, Frederick Raal, Kamy Chetty, Koleka Mlisana, Jaya A George","doi":"10.1136/bmjph-2023-000799","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) has emerged as a substantial global health challenge, with a marked rise in associated mortality. However, it often goes undetected until advanced stages, particularly in low-income and middle-income countries such as South Africa. We investigated the prevalence and progression of CKD in South Africa, utilising a subset of data from the National Health Laboratory Services Multi-morbidity Cohort.</p><p><strong>Methods: </strong>This study was a retrospective analysis of adults aged 18-85 years who underwent initial creatinine laboratory testing at government hospitals and clinics from January 2012 to January 2016. CKD was assessed using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, excluding the race factor, with a cut-off of CKD-EPI<60 mL/min/1.73 m<sup>2</sup>. Lab-diagnosed CKD was defined as two estimated glomerular filtration rate measurements <60 mL/min/1.73 m<sup>2</sup> at least 90 days apart. Cox regression and survival curves were used to estimate HRs and rates of progression.</p><p><strong>Results: </strong>Among 6 106 521 adults tested between 2012 and 2016, 1.5% (95% CI 1.4% to 1.5%) were diagnosed with CKD, with the majority in stage 3. Over follow-up (median: 2 years, IQR: 0.8-3.6 years), 28.2% (95% CI 27.7% to 28.6%) of patients diagnosed as stage 3a progressed to a more severe disease state. Among patients who were in stage 3b at diagnosis, 29.6% (95% CI 29.0% to 30.1%) progressed and 33.3% (95% CI 32.5% to 34.1%) of stage 4 patients progressed. We estimated a 48% higher adjusted hazard of CKD progression for individuals with diabetes (adjusted HR 1.48, 95% CI 1.41 to 1.57) compared with those without. Advancing age also increased the risk, particularly for those aged >50 years.</p><p><strong>Conclusions: </strong>This study underscores the urgency for early detection and management of CKD in South Africa, particularly for high-risk individuals. Strengthening primary healthcare systems and raising CKD awareness are vital for improved patient outcomes and to alleviate the burden on healthcare resources. Early intervention can delay CKD progression, thus reducing the need for costly treatments like dialysis and transplantation.</p>","PeriodicalId":101362,"journal":{"name":"BMJ public health","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654635/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence and progression of chronic kidney disease among adults undergoing creatinine testing in South African public healthcare facilities: a study leveraging data from South Africa's National Health Laboratory Service (NHLS).\",\"authors\":\"Alana T Brennan, Emma M Kileel, Siyabonga Khoza, Nigel J Crowther, Jacob Bor, Matthew P Fox, Sydney Rosen, Patricia Hibberd, Frederick Raal, Kamy Chetty, Koleka Mlisana, Jaya A George\",\"doi\":\"10.1136/bmjph-2023-000799\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chronic kidney disease (CKD) has emerged as a substantial global health challenge, with a marked rise in associated mortality. However, it often goes undetected until advanced stages, particularly in low-income and middle-income countries such as South Africa. We investigated the prevalence and progression of CKD in South Africa, utilising a subset of data from the National Health Laboratory Services Multi-morbidity Cohort.</p><p><strong>Methods: </strong>This study was a retrospective analysis of adults aged 18-85 years who underwent initial creatinine laboratory testing at government hospitals and clinics from January 2012 to January 2016. CKD was assessed using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, excluding the race factor, with a cut-off of CKD-EPI<60 mL/min/1.73 m<sup>2</sup>. Lab-diagnosed CKD was defined as two estimated glomerular filtration rate measurements <60 mL/min/1.73 m<sup>2</sup> at least 90 days apart. Cox regression and survival curves were used to estimate HRs and rates of progression.</p><p><strong>Results: </strong>Among 6 106 521 adults tested between 2012 and 2016, 1.5% (95% CI 1.4% to 1.5%) were diagnosed with CKD, with the majority in stage 3. Over follow-up (median: 2 years, IQR: 0.8-3.6 years), 28.2% (95% CI 27.7% to 28.6%) of patients diagnosed as stage 3a progressed to a more severe disease state. Among patients who were in stage 3b at diagnosis, 29.6% (95% CI 29.0% to 30.1%) progressed and 33.3% (95% CI 32.5% to 34.1%) of stage 4 patients progressed. We estimated a 48% higher adjusted hazard of CKD progression for individuals with diabetes (adjusted HR 1.48, 95% CI 1.41 to 1.57) compared with those without. Advancing age also increased the risk, particularly for those aged >50 years.</p><p><strong>Conclusions: </strong>This study underscores the urgency for early detection and management of CKD in South Africa, particularly for high-risk individuals. Strengthening primary healthcare systems and raising CKD awareness are vital for improved patient outcomes and to alleviate the burden on healthcare resources. Early intervention can delay CKD progression, thus reducing the need for costly treatments like dialysis and transplantation.</p>\",\"PeriodicalId\":101362,\"journal\":{\"name\":\"BMJ public health\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654635/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ public health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjph-2023-000799\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjph-2023-000799","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:慢性肾脏疾病(CKD)已成为一个重大的全球健康挑战,其相关死亡率显著上升。然而,它往往直到晚期才被发现,特别是在南非等低收入和中等收入国家。我们调查了南非慢性肾病的患病率和进展,利用了来自国家卫生实验室服务多发病队列的数据子集。方法:本研究对2012年1月至2016年1月在政府医院和诊所进行初始肌酐实验室检测的18-85岁成年人进行回顾性分析。使用慢性肾脏疾病流行病学合作(CKD- epi)方程评估CKD,排除种族因素,以CKD- epi2为截止值。实验室诊断的CKD定义为间隔至少90天的两次肾小球滤过率测量。使用Cox回归和生存曲线来估计hr和进展率。结果:在2012年至2016年期间检测的6 106 521名成年人中,1.5% (95% CI 1.4%至1.5%)被诊断为CKD,其中大多数处于3期。在随访期间(中位:2年,IQR: 0.8-3.6年),诊断为3a期的患者中有28.2% (95% CI 27.7% - 28.6%)进展为更严重的疾病状态。在诊断时处于3b期的患者中,29.6% (95% CI 29.0%至30.1%)的患者进展,33.3% (95% CI 32.5%至34.1%)的4期患者进展。我们估计糖尿病患者CKD进展的校正风险比无糖尿病患者高48%(校正HR 1.48, 95% CI 1.41 - 1.57)。年龄的增长也会增加患病的风险,尤其是那些50岁左右的人。结论:这项研究强调了南非早期发现和管理CKD的紧迫性,特别是对高危人群。加强初级卫生保健系统和提高CKD意识对于改善患者预后和减轻医疗资源负担至关重要。早期干预可以延缓CKD的进展,从而减少透析和移植等昂贵治疗的需要。
Prevalence and progression of chronic kidney disease among adults undergoing creatinine testing in South African public healthcare facilities: a study leveraging data from South Africa's National Health Laboratory Service (NHLS).
Background: Chronic kidney disease (CKD) has emerged as a substantial global health challenge, with a marked rise in associated mortality. However, it often goes undetected until advanced stages, particularly in low-income and middle-income countries such as South Africa. We investigated the prevalence and progression of CKD in South Africa, utilising a subset of data from the National Health Laboratory Services Multi-morbidity Cohort.
Methods: This study was a retrospective analysis of adults aged 18-85 years who underwent initial creatinine laboratory testing at government hospitals and clinics from January 2012 to January 2016. CKD was assessed using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, excluding the race factor, with a cut-off of CKD-EPI<60 mL/min/1.73 m2. Lab-diagnosed CKD was defined as two estimated glomerular filtration rate measurements <60 mL/min/1.73 m2 at least 90 days apart. Cox regression and survival curves were used to estimate HRs and rates of progression.
Results: Among 6 106 521 adults tested between 2012 and 2016, 1.5% (95% CI 1.4% to 1.5%) were diagnosed with CKD, with the majority in stage 3. Over follow-up (median: 2 years, IQR: 0.8-3.6 years), 28.2% (95% CI 27.7% to 28.6%) of patients diagnosed as stage 3a progressed to a more severe disease state. Among patients who were in stage 3b at diagnosis, 29.6% (95% CI 29.0% to 30.1%) progressed and 33.3% (95% CI 32.5% to 34.1%) of stage 4 patients progressed. We estimated a 48% higher adjusted hazard of CKD progression for individuals with diabetes (adjusted HR 1.48, 95% CI 1.41 to 1.57) compared with those without. Advancing age also increased the risk, particularly for those aged >50 years.
Conclusions: This study underscores the urgency for early detection and management of CKD in South Africa, particularly for high-risk individuals. Strengthening primary healthcare systems and raising CKD awareness are vital for improved patient outcomes and to alleviate the burden on healthcare resources. Early intervention can delay CKD progression, thus reducing the need for costly treatments like dialysis and transplantation.